bedaquiline and Kidney-Failure--Chronic

bedaquiline has been researched along with Kidney-Failure--Chronic* in 1 studies

Other Studies

1 other study(ies) available for bedaquiline and Kidney-Failure--Chronic

ArticleYear
The use of bedaquiline to treat patients with multidrug-resistant tuberculosis and end-stage renal disease: A case report.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2018, Volume: 76

    The use of bedaquiline to treat patients with multidrug-resistant tuberculosis (MDR-TB) and end-stage renal disease (ESRD) may raise safety concerns. Currently, no clinical information is available on the use of bedaquiline to treat MDR-TB patients with ESRD. We report the use of bedaquiline to treat two patients with MDR-TB and ESRD. This report highlights the safety and tolerability of bedaquiline as well as the treatment outcome. The use of bedaquiline in patients with ESRD is also discussed.

    Topics: Antitubercular Agents; Diarylquinolines; Humans; Kidney Failure, Chronic; Male; Middle Aged; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2018